Cha Hospital Holds 2nd National University of Singapore CHA Symposium...the topic of development in reproductive medicine
Nov 13, 2025
On the 10th, Cha Medical University and Cha Hospital held the 2nd NUS-CHA Symposium' at St. Regis Singapore in Singapore with the National University of Singapore under the theme of 「Asia-Pacific Reproductive Medicine Development and New Wave」. The National University of Singapore is the world's best university, ranked 8th in the world university evaluation and 1st in Asia.
Cha Kwang-ryul Cha Hospital and Cha Bio attended the symposium on this dayThe group's director of the Global Research Institute, Hong Jin-wook, Korean ambassador to Singapore, Chung Yup-saeng, president of the National University of Singapore Medical School, Hwang Jong-wei, vice director of the National University of Singapore Medical School, and Yun Ho-seop, vice president of the research department at Cha Medical University, attended. In addition, world-class researchers, including professors at the University of Technology Sydney, gathered to suggest the development of reproductive medicine in the Asia-Pacific region and the direction of aging and cell therapy.
On this day, Cha Kwang-ryul, head of the research institute, gave a special lecture on the theme of 「Oxygen Aging and Excellence of K Cell」.
Director of the research center Cha said, `The researchers at Cha Hospital conducted an ovarian recovery study using MPC (intermediate leaf stem cells) made from embryonic stem cells, placenta, and blood, and secured meaningful results such as recovery of ovulation cycle, increased estrogen secretion, and reduction of follicle cell death in naturally aged mice""Cell therapy will be a game changer for human aging and disease treatment. " He then explained the characteristics of cell therapy drugs being developed in Korea, Japan, and the United States, respectively, and the excellence of K-cells, and said "Let's study together and cooperate in developing cell therapy together."
Chung Yup-saeng, president of the National University of Singapore Medical School, said "I found Cha's insights on cell therapy and K-cell interesting and surprising."In particular, as shown in Cha's announcement, if stem cell injection can improve reproductive function, the impact will be great. "IVF aids pregnancy but does not restore ovarian function. Cell therapy that delays and regenerates ovarian aging in women is a breakthrough and promising treatment direction in both clinical and public health. " In addition, he added "In the future, based on clinical scientific strengths, Cha Hospital and Cha Bio will continue to do so."We will actively engage in seminars and exchanges through cooperative relationships with the group."
Korean Ambassador to Singapore Hong Jin-wook "This year marks the 50th anniversary of exchanges between Korea and Singapore, and I am grateful to both organizations for hosting this meaningful event."I look forward to more active exchanges in the future."
This event will be held on ▲ Microfluidic and AI-based platforms for next-generation assisted reproduction (Professor Majid Warquiani of the Technical University of Sydney) ▲ Cell Aging in ovary aging (Professor Jeon Ok-hee of Korea University) ▲AI-based 3D imaging: Looking beyond what is visible in embryo selection (Professor Bundang Cha Hospital Kim Hyang-ki), ▲ A new artificial endometrial model for in vitro embryo implantation (Director Lee Kyung-ah of the Reproductive Medicine Division of Cha Hospital) ▲IVF enhancement, KKIVF Experience (Dr. Melissa Durgashri Tarmalingan, chief embryoologist at the KKIVF Center, KKK Women's and Children's Hospital, Singapore) ▲IVF laboratory automation (Professor Jerry Chan-Kok Yan, University of Singapore-Duke Medical School) ▲Separate selection (Dr. Rio Swirian, Center for Infertility, Singapore) and others announced.
This is the second time that the CHA Symposium with the National University of Singapore held the first symposium in Korea after signing a business agreement for joint research and academic exchanges in 2024. The two universities are striving to cultivate global future talents in reproductive medicine by sharing and utilizing human, physical, and intellectual infrastructure.
Cha Kwang-ryul Cha Hospital and Cha Bio attended the symposium on this dayThe group's director of the Global Research Institute, Hong Jin-wook, Korean ambassador to Singapore, Chung Yup-saeng, president of the National University of Singapore Medical School, Hwang Jong-wei, vice director of the National University of Singapore Medical School, and Yun Ho-seop, vice president of the research department at Cha Medical University, attended. In addition, world-class researchers, including professors at the University of Technology Sydney, gathered to suggest the development of reproductive medicine in the Asia-Pacific region and the direction of aging and cell therapy.
On this day, Cha Kwang-ryul, head of the research institute, gave a special lecture on the theme of 「Oxygen Aging and Excellence of K Cell」.
Director of the research center Cha said, `The researchers at Cha Hospital conducted an ovarian recovery study using MPC (intermediate leaf stem cells) made from embryonic stem cells, placenta, and blood, and secured meaningful results such as recovery of ovulation cycle, increased estrogen secretion, and reduction of follicle cell death in naturally aged mice""Cell therapy will be a game changer for human aging and disease treatment. " He then explained the characteristics of cell therapy drugs being developed in Korea, Japan, and the United States, respectively, and the excellence of K-cells, and said "Let's study together and cooperate in developing cell therapy together."
Chung Yup-saeng, president of the National University of Singapore Medical School, said "I found Cha's insights on cell therapy and K-cell interesting and surprising."In particular, as shown in Cha's announcement, if stem cell injection can improve reproductive function, the impact will be great. "IVF aids pregnancy but does not restore ovarian function. Cell therapy that delays and regenerates ovarian aging in women is a breakthrough and promising treatment direction in both clinical and public health. " In addition, he added "In the future, based on clinical scientific strengths, Cha Hospital and Cha Bio will continue to do so."We will actively engage in seminars and exchanges through cooperative relationships with the group."
Korean Ambassador to Singapore Hong Jin-wook "This year marks the 50th anniversary of exchanges between Korea and Singapore, and I am grateful to both organizations for hosting this meaningful event."I look forward to more active exchanges in the future."
This event will be held on ▲ Microfluidic and AI-based platforms for next-generation assisted reproduction (Professor Majid Warquiani of the Technical University of Sydney) ▲ Cell Aging in ovary aging (Professor Jeon Ok-hee of Korea University) ▲AI-based 3D imaging: Looking beyond what is visible in embryo selection (Professor Bundang Cha Hospital Kim Hyang-ki), ▲ A new artificial endometrial model for in vitro embryo implantation (Director Lee Kyung-ah of the Reproductive Medicine Division of Cha Hospital) ▲IVF enhancement, KKIVF Experience (Dr. Melissa Durgashri Tarmalingan, chief embryoologist at the KKIVF Center, KKK Women's and Children's Hospital, Singapore) ▲IVF laboratory automation (Professor Jerry Chan-Kok Yan, University of Singapore-Duke Medical School) ▲Separate selection (Dr. Rio Swirian, Center for Infertility, Singapore) and others announced.
This is the second time that the CHA Symposium with the National University of Singapore held the first symposium in Korea after signing a business agreement for joint research and academic exchanges in 2024. The two universities are striving to cultivate global future talents in reproductive medicine by sharing and utilizing human, physical, and intellectual infrastructure.
|
This article was translated by Naver AI translator.
